Artikel von Marvin Herzberger
Marvin Herzberger is a publishing trader at TraderFox GmbH and group leader for the technical analysis of the DAX. He has been actively engaged in technical analysis since 2011. In this context, he has tested, analyzed, and evaluated various trading strategies in practical implementation. His area of expertise lies in swing trading. The analyses cover a short-term time horizon of up to 10 days.Latest from Marvin Herzberger
Candel Therapeutics: Compelling Clinical Phase 3 Data and a $22 Price Target by Stifel!
Candel Therapeutics (CADL) recently published crucial Phase 3 data (PrTK03) for its lead candidate Aglatimagene...
BASF: Will the IPO Plans for the Agricultural Business Trigger a Revaluation?
On July 13, BASF SE was able to draw attention with relative strength. The impetus for this was the management's...
Intel: $5.7 Billion Bet on Its Own Foundry Future in Europe
Investment of $5.7 billion in the Irish site of Leixlip to expand semiconductor manufacturing. The...
DHL Group: Forecast Upgrade and the Express Business as a Dominant Factor in Earnings Expectations
The DHL Group raised its annual EBIT forecast to over 6.5 billion euros on July 7 following preliminary...
Alpha Cognition: Zunveyl growth and new studies strengthen its profile in the Alzheimer's market
Raymond James initiated coverage of the stock of Alpha Cognition (ACOG) on July 10, 2026, with an "Outperform"...
Vodafone: Is a European Billionaire Becoming a new Power Factor at Vodafone?
Emirates Telecom sells its 16.21% stake in Vodafone for nearly $6 billion to Xavier Niel's investment...
Visa: Strategic Expansion of Market Share in the European Card Business
Commerzbank is gradually replacing Mastercard with Visa in its credit card portfolio. For Visa,...
Oracle: 45% Price Drop in Five Weeks - I'm Betting on a Trend Reversal Now!
The Oracle stock (i.) has dropped by around 45% from $250.25 on June 1 to $137.55 on July 7. One of the...
Adobe: The Sell-Off Panic Offers Patient Investors an Interesting Entry Opportunity!
In the stock market, it can often happen that prices are temporarily moved by emotions such as panic...
Bloom Energy: Facts on the Short Seller Attack and the Company's Response
Hunterbrook Media criticized Bloom's finances and scandium supply chains. Bloom refuted any dependence...
BioAge Labs: How Novo Nordisk's ZEUS Study Could Validate the Market for the NLRP3 Inhibitor BGE-102
In mid-June 2026, BioAge Labs (BIOA) dosed the first patient in the QUELL-CV study to test the oral...
Revenue Drivers AI Packaging: An Analytical Look at the Current Figures from ASE Technology
The consolidated net revenue increased by 32.9% year-on-year in June 2026. The Assembly, Testing,...
Hannover Re: Full Marks in our Robustness Check Win Over Investors!
The robustness check confirms Hannover Re with 15 out of 15 possible points, indicating a high stability...
FDA Approval and Accelerated Efficacy Data: How Vera Therapeutics Addresses the Multi-Billion Dollar Kidney Disease Market with Trutakna
Classification of the FDA Decision and Market Dynamics On July 7, 2026, the California-based biotech...
Broadcom: The $30 Billion Deal with Apple and Its Consequences for Broadcom's ASIC Division
Apple extends the Broadcom contract until 2031 to over $30 billion. Broadcom invests $1.5 billion...
Alibaba Stock Rises by 9%: Turning Point in Instant Commerce? Alibaba's Signal Before Quarterly Results
Alibaba's stock price reacts positively to signals that losses in the instant commerce segment are...
AtaiBeckley: Canaccord Raises Target to $17 and Praises Progress in DMT Buccal Film Study!
The biopharma sector continues to experience steady interest in companies dedicated to developing novel...
Axon Enterprise: The World Cup as a Catalyst - With Drone Defense to New Market Shares
Needham raised the price target to $750 due to the stable order situation for Q2 and Q3. The LAPD...
Straumann: Forecast Upgrade and a 52-Week High - I See Further Potential!
Currently, there are observable trends of reallocation in the market. Investors are taking profits from...
Lockheed Martin: Are "Reconciliation 3.0" and the "Save America Act" potential catalysts for the stock?
The $350 billion defense package could solidify long-term demand for LMT systems. The company will...